Sponsored Content

Naturmega: Redefining omega-3 nutrition for Asia

Asia’s omega-3 market is driven by premiumisation, algae growth, and clinical backing. Naturmega, an advanced lipid innovation partner, brings high-purity, sustainable lipid innovation to Vitafoods Asia.

Asia-Pacific’s omega-3 market is evolving rapidly, fuelled by premiumisation, plant-based preferences, and rising demand for clinically supported products. According to the GOED 2025 Ingredient Market Report, the region grew by 2.0% in volume in 2024, reaching 11,167 metric tons, while value increased 11.2% to US$251.9 million. This upward trajectory reflects shifting consumer priorities towards purity, sustainability, and innovation, with growth forecast to continue at a 2.7% CAGR through 2027.

South Korea remains Asia-Pacific’s largest omega-3 market, accounting for a significant share of supplement sales. After a slight decline in 2023, it rebounded in 2024, driven by its advanced nutraceutical sector and consumer appetite for premium health solutions. South Korean consumers prioritise high-efficacy products with proven science, which has intensified demand for high-concentration oils and novel delivery forms.

Notably, algae-based omega-3 oils are gaining momentum, growing 8.4% in South Korea’s dietary supplement sector in 2024, although they still account for less than 2% of the market (GOED 2025 Ingredient Market Report). This underscores a clear opportunity for innovation in plant-based alternatives that align with the region’s growing flexitarian and vegan trends.

Beyond South Korea, broader Asia-Pacific markets – including Japan, China, and Southeast Asia – are also shifting towards high-quality, clinically validated omega-3s. In Japan, omega-3 products remain strongly associated with cardiovascular and cognitive health, while in China and Southeast Asia, categories such as women’s health and early-life nutrition are expanding rapidly.

Premiumisation is evident across the region: consumers are seeking IFOS-certified, traceable, and sustainably sourced omega-3 oils, with increased interest in advanced formats such as very high concentrates and phospholipid-based technologies. This shift signals a demand for ingredients that deliver both measurable outcomes and clean-label credentials.

As a leading advanced lipid manufacturer in Latin America, Naturmega is uniquely positioned to support Asia-Pacific brands seeking to meet these evolving demands. With over 17 years of expertise, Naturmega combines cutting-edge technology, including the region’s first supercritical CO₂ fractionation facility, with a deep commitment to sustainability and science-driven innovation.

Naturmega’s certified operations – which include IFOS, IAOS, Friend of the Sea, V-Label, and Halal – ensure exceptional quality, traceability, and alignment with global standards. This foundation enables the company to deliver differentiated lipid solutions across nutraceutical, pharmaceutical, and functional food applications.

Naturmega’s portfolio directly addresses the most dynamic areas of the omega-3 market:

• EssentiOmega® Nova: High-concentration fish oils designed for premium supplements and clinical-grade formulations.

• EssentiOmega® Algae: Plant-based high DHA omega-3 concentrates catering to the growing vegetarian and vegan segments in Asia-Pacific.

• Ruby-O® (BPL03TM Technology): A patented phospholipid-bonded omega-3 platform developed to enhance bioavailability, support multi-nutrient delivery, and enable next-generation formulations.

Sustainability is no longer optional; it is an expectation. Naturmega integrates responsible sourcing and eco-conscious production into its operations, ensuring full transparency from raw material to finished ingredients. Its advanced lipid innovation centre in Colombia underscores this approach, enabling scalable solutions that balance performance with environmental stewardship.

Naturmega will be showcasing its portfolio and innovations at Vitafoods Asia 2025 (17-19 September, Bangkok), within the GOED Omega-3 Pavilion. Attendees will have the opportunity to explore how Naturmega is redefining omega-3 nutrition for Asia, from high-purity concentrates and plant-based solutions to Ruby-O’s next-generation phospholipid technology.

From algae to next-generation omega-3, Naturmega is redefining lipid science, delivering purity, sustainability, and clinically aligned innovation for the markets that matter most.

For more information visit: www.naturmega.com

This piece of content is provided by an advertiser or created on behalf of an advertiser. The views or opinions expressed in this piece of content do not reflect those of Informa.